REDWOOD CITY, CA–(EMWNews – August 7, 2008) – BioCentury Publications, Inc. has

appointed Thomas C. Carey as its Vice President of Commercial Operations.

Mr. Carey brings a proven track record of successful leadership in business

operations, sales and marketing management, and business and corporate

development with major life sciences companies. He will be responsible for

leading the sales organization, product and event marketing, and partner

management in addition to being a key member of the senior leadership team

at BioCentury.

“Tom adds extensive commercial expertise to our management team,” said

David Flores, President and CEO of BioCentury. “His in-depth knowledge of

the biotech and pharmaceutical marketplace and experience in strategic

commercial operations and organizational leadership will be vital to

BioCentury as we continue to expand our industry footprint. We are

confident he is the right person to take us to the next level of commercial

success as an independent source of business analysis and data.”

Previously, Mr. Carey was Senior Vice President of Sales and Marketing for

Connetics Corporation, a $220 million company focused on dermatology. At

Connetics, he was responsible for leading the commercial organization,

which included sales, sales operations, marketing, professional relations,

and strategic accounts. Prior to Connetics, he served as Vice President of

Professional Sales as well as Vice President of Business Development at

OrthoNeutrogena, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

He also has held senior management positions at Roche Laboratories, Inc.

and Syntex Corporation.

Mr. Carey holds an MBA in marketing and general management and a BA in

biopsychology from the University of California, Berkeley.

“I am excited to join the BioCentury team at this transformational point in

the company’s history,” said Mr. Carey. “BioCentury is an industry leader

with an enviable reputation. It is recognized internationally as the

leader in providing accurate and insightful business and scientific

intelligence across the biopharma value chain. With the recent launches of

the BCIQ biopharma database and SciBx, the first product from BioCentury’s

joint publishing partnership with Nature Publishing Group, the company is

well positioned for explosive growth. I look forward to working with David

Flores, Dr. Karen Bernstein, and the entire BioCentury team to continue to

build a great company.”

About BioCentury

BioCentury Publications, Inc. is an independently owned and operated

company based in Redwood City, Calif., that provides essential biopharma

industry intelligence from five offices in the U.S. and Europe. Over the

past 15 years, a global audience of biotech and pharmaceutical executives

and investors has benefited from BioCentury’s deep knowledge, data-driven

analysis and independent perspective. BioCentury’s trustworthy content is

available through the company’s publications, including BioCentury, the

Bernstein Report on BioBusiness and the new SciBX: Science-Business

eXchange, as well as its BCIQ: BioCentury Online Intelligence database,

which helps filter, analyze and identify candidates from more than 4,000

companies, 5,000 compounds and $200 billion in financing transactions, and

its collaborative industry conferences in the U.S., Europe and Asia. For

more information, visit www.biocentury.com.

BioCentury®; The Bernstein Report on BioBusiness®; The BioCentury

100™; The Clear Route to ROI™, Because Real Intelligence is Hard to

Find™; BCIQ™; BioPharma’s Knowledge Center™, and SciBX™ are

trademarks of BIOCENTURY PUBLICATIONS, INC. Copyright © 2008. ALL RIGHTS

RESERVED.